Pancreatic Cancer Research

ResearcherLoyola University Medical CenterNo recent work listed

Daniel V.T. Catenacci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7517-8020; OpenAlex author ID A5084809433. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 1, last author 0)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 trial

Papers 5

  1. Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. Co-author DOI 10.1002/jso.24872↗
  2. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000458↗
  3. How can next-generation diagnostics aid pancreatic adenocarcinoma treatment? First author DOI 10.2217/fon.15.353↗
  4. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. Co-author DOI 10.1200/jco.2015.62.8719↗
  5. A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcino… Co-author DOI 10.1186/2051-1426-1-8↗

Trials 2

  1. Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies Principal investigator NCT04361708↗
  2. Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuro… Principal investigator NCT01416714↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hedy Lee Kindler · 4 shared papers, 2013–2018 · strength 0.20
  2. Shuang Qin Zhang · 1 shared paper, 2016 · strength 0.12
  3. Robert Marsh · 2 shared papers, 2015–2018 · strength 0.11
  4. Blasé N. Polite · 2 shared papers, 2013–2018 · strength 0.11
  5. Marshall S. Baker · 1 shared paper, 2018 · strength 0.07
  6. Marina Talamonti · 1 shared paper, 2018 · strength 0.07
  7. Kevin King Roggin · 1 shared paper, 2018 · strength 0.07
  8. Jeffrey B. Matthews · 1 shared paper, 2018 · strength 0.07
  9. Mitchell C. Posner · 1 shared paper, 2018 · strength 0.07
  10. Andrew H. Ko · 1 shared paper, 2016 · strength 0.05
  11. Evan Justin Walker · 1 shared paper, 2016 · strength 0.05
  12. Noelle K. LoConte · 1 shared paper, 2016 · strength 0.05
  13. Alan Paul Venook · 1 shared paper, 2016 · strength 0.05
  14. Margaret A. Tempero · 1 shared paper, 2016 · strength 0.05
  15. Deirdre Jill Cohen · 1 shared paper, 2015 · strength 0.04
  16. Heinz‐Josef Lenz · 1 shared paper, 2015 · strength 0.04
  17. Melissa R. Junttila · 1 shared paper, 2015 · strength 0.04
  18. Nathan Bahary · 1 shared paper, 2015 · strength 0.04
  19. Ravi Salgia · 1 shared paper, 2015 · strength 0.04
  20. Daniel M. Geynisman · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.